Materials you may find helpful in your exploration of the use of JYSELECA in the treatment of adult patients with moderately to severely active ulcerative colitis

How are expanding therapeutic options raising expectations for treatment success in UC?

Dr Phil Smith from the University of Liverpool and Professor Glen Doherty from the University College Dublin School of Medicine explore how expanding treatment options can advance expectations for treatment success in UC, and consider when JYSELECA may be an appropriate choice to help improve patient outcomes.

JYSELECA: insights from ECCO’22

Dr Alissa Walsh from Oxford University Hospitals and Dr Daniel Gaya from the University of Glasgow Medical School examine JYSELECA data presented at ECCO 2022 and consider the implications for its use in clinical practice.